A clinical study of oropharynx and hypopharynx cancer with Rouvière lymph node metastasis

  • Kyono Mari
    Department of Otorhinolaryngology-Head and Neck Surgery, Kyusyu University Hospital
  • Hashimoto Kazuki
    Department of Otorhinolaryngology-Head and Neck Surgery, Kyusyu University Hospital
  • Matsuo Mioko
    Department of Otorhinolaryngology-Head and Neck Surgery, Kyusyu University Hospital
  • Kogo Ryunosuke
    Department of Otorhinolaryngology-Head and Neck Surgery, Kyusyu University Hospital
  • Jiromaru Rina
    Department of Otorhinolaryngology-Head and Neck Surgery, Kyusyu University Hospital
  • Hongo Takahiro
    Department of Otorhinolaryngology-Head and Neck Surgery, Kyusyu University Hospital
  • Manako Tomomi
    Department of Otorhinolaryngology-Head and Neck Surgery, Kyusyu University Hospital
  • Wakiyama Hiroaki
    Department of Clinical Radiology, Kyusyu University Hospital
  • Nakagawa Takashi
    Department of Otorhinolaryngology-Head and Neck Surgery, Kyusyu University Hospital

Bibliographic Information

Other Title
  • ルビエールリンパ節転移を有する中咽頭・下咽頭癌症例の臨床検討

Search this article

Description

Patients with advanced pharyngeal carcinoma often develop metastasis to the lateral retropharyngeal lymph node (RLN; Rouvière lymph node), but there are few reports on the treatment of RLN metastatic lesions, and no unified opinion has been reached. In this study, we reviewed 22 cases of squamous cell carcinoma of the oropharyngeal and hypopharynx that had RLN metastasis at the time of initial treatment at our hospital. Initial treatment included 11 cases of surgery and 11 cases of chemoradiotherapy. Of the patients who underwent surgery, 3 patients had RLN metastatic lesions resected and in the remaining 8 patients, RLN metastatic lesions were not resected and postoperative radiation therapy was administered. The recurrence rate of RLN was 18.2% of all cases, and the control of RLN lesions was relatively good even in cases treated with chemoradiotherapy alone. Regardless of whether the RLN was controlled after treatment, the distant metastasis rate was especially high for hypopharyngeal cancer at 66.7%, indicating a poor prognosis. Therefore, more rigorous metastatic follow-up is required after treatment in cases of hypopharyngeal cancer.

Journal

  • Toukeibu Gan

    Toukeibu Gan 50 (4), 298-303, 2024

    Japan Society for Head and Neck Cancer

References(2)*help

See more

Details 詳細情報について

Report a problem

Back to top